|
|
|
|
| LEADER |
03578nam a22003255i 4500 |
| 001 |
978-94-011-3134-6 |
| 005 |
20191025162227.0 |
| 007 |
cr nn 008mamaa |
| 008 |
121227s1991 ne | s |||| 0|eng d |
| 020 |
|
|
|a 9789401131346
|
| 024 |
7 |
|
|a 10.1007/978-94-011-3134-6
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 100 |
1 |
|
|a Kruk, Z.L.
|e author.
|
| 245 |
1 |
0 |
|a Neurotransmitters and Drugs
|c by Z.L. Kruk, C. Pycock.
|
| 250 |
|
|
|a 3rd ed. 1991.
|
| 260 |
# |
# |
|a Dordrecht :
|b Springer Netherlands :
|b Imprint: Springer,
|c 1991.
|
| 300 |
|
|
|a IX, 204 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Croom Helm Biology in Medicine Series
|
| 505 |
0 |
|
|a 1 Neurotransmission: Sites at which drugs modify neurotransmission -- 1.1 The neurone -- 1.2 Axonal transport -- 1.3 Neuronal cell membranes -- 1.4 Precursors -- 1.5 Synthesis -- 1.6 Storage -- 1.7 Organelles and enzymes -- 1.8 Release -- 1.9 Receptors -- 1.10 Inactivation -- 1.11 Neurotransmitters or neuromodulators -- 1.12 Neurotransmitters in the nervous system -- 1.13 Neurotransmitters and drugs -- Further reading -- 2 Acetylcholine -- 2.1 Synthesis -- 2.2 Storage -- 2.3 Release -- 2.4 Cholinergic receptors -- 2.5 Inactivation of acetylcholine -- 2.6 Therapeutic applications and consequences of drugs acting at cholinergic synapses -- Further reading -- 3 Noradrenaline -- 3.1 Synthesis -- 3.2 Storage -- 3.3 Release -- 3.4 Adrenoreceptors -- 3.5 Inactivation of noradrenaline -- 3.6 Therapeutic applications and consequences of drugs acting at noradrenergic synapses -- Further reading -- 4 Dopamine -- 4.1 Synthesis -- 4.2 Storage -- 4.3 Release -- 4.4 Dopamine systems -- 4.5 Inactivation of dopamine -- 4.6 Therapeutic applications and consequences of drugs acting at dopaminergic synapses -- Further reading -- 5 5-Hydroxytryptamine -- 5.1 Synthesis -- 5.2 Storage -- 5.3 Release -- 5.4 5-HT receptors -- 5.5 Inactivation of 5-HT -- 5.6 Therapeutic applications and consequences of drugs acting at 5-HT synapses -- Further reading -- 6 Histamine -- 6.1 Synthesis -- 6.2 Storage -- 6.3 Release -- 6.4 Histamine receptors -- 6.5 Inactivation of histamine -- 6.6 Therapeutic applications and consequences of drug action on histamine systems -- Further reading -- 7 Inhibitory amino acids: GABA, glycine and taurine -- 7.1 Amino acids as neurotransmitters -- 7.2 ?-aminobutyric acid -- 7.3 Glycine -- 7.4 Taurine -- Further reading -- 8 Excitory amino acids: L-glutamic acid and L-aspartic acid -- 8.1 Synthesis -- 8.2 Storage -- 8.3 Release -- 8.4 Excitatory amino acid receptors in the CNS -- 8.5 Inactivation of released excitory amino acids -- 8.6 Functional roles of cerebral excitory amino acid neurotransmitters -- Further reading -- 9 Peptides and neuronal function -- 9.1 Peptides as neurotransmitters and hormones -- 9.2 Synthesis, storage, transport, release and inactivation of neuropeptides -- 9.3 Co-existence and co-transmission of peptides with classical neurotransmitters -- 9.4 Opioid peptides -- 9.5 Substance P (the tachykinins) -- 9.6 Cholecystokinin (CCK) -- 9.7 Vasoactive intestinal polypeptide -- 9.8 Neurotensin -- 9.9 Somatostatin -- 9.10 Bombesin -- Further reading.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
|
0 |
|a Neurosciences.
|
| 650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
| 650 |
2 |
4 |
|a Neurosciences.
|
| 700 |
1 |
|
|a Pycock, C.
|e author.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-94-011-3134-6
|